KRKA - Judgement in litigation relating to alleged infringement of the patent relating to montelukast in Slovenia

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 8 / 2013

Date of issue: 2013-03-01

Short name of the issuer

KRKA

Subject

Judgement in litigation relating to alleged infringement of the patent relating to montelukast in Slovenia

Official market - legal basis

Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne

Unofficial market - legal basis

Contents of the report:

Krka, d. d., Novo mesto (hereinafter as “Krka") announces to the interested public that in the litigation for alleged infringement of patent relating to the active ingredient montelukast, Krka received the judgement of the Supreme Court of Republic of Slovenia which refused the request for revision filed by Merck Frosst Canada Limited, Purdy's Wharf Tower One, 1959 Upper Water Street, Halifax, Nova Scotia, Canada and confirmed the decision of the Appeal Court in Ljubljana dated on 10 May 2012. The litigation in Slovenia is over. Krka published the information relating to montelukast dispute in Slovenia on 13 July 2012, 23 March 2010, 23 April 2009, 5 December 2008, 13 March 2008 and 14 June 2007.

Annexes

File Description

Judgement montelukast Slovenia.pdf Final judgement for montelukast in Slovenia

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

8501 Nove Mesto

(post code) (city)

Smarjeska 6

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nie dotyczy

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2013-03-01 Jo¾e Colariè President of the Management and Chief Executive